Alyglo™ (immune globulin intravenous, human-stwk) – New drug approval
December 17, 2023 - GC Biopharma announced the FDA approval of Alyglo (immune globulin intravenous, human-stwk), for the treatment of primary humoral immunodeficiency (PI) in adults.
Download PDF
